Results 161 to 170 of about 5,817 (208)

Crystal structure and nanobodies against domain 3 of the malaria parasite fusogen Plasmodium falciparum HAP2. [PDF]

open access: yesBiochem J
Lyons FMT   +11 more
europepmc   +1 more source

Next Generation SICLOPPS Screening for the Identification of Inhibitors of the HIF-1α/HIF-1β Protein-Protein Interaction. [PDF]

open access: yesACS Chem Biol
McDermott A   +5 more
europepmc   +1 more source

Development of novel neutralizing single-chain fragment variable antibodies against S100A8. [PDF]

open access: yesSci Rep
Raeisi H   +7 more
europepmc   +1 more source

Identification of Variable Lymphocyte Receptors That Target the Human Blood-Brain Barrier. [PDF]

open access: yesPharmaceutics
Katt ME   +5 more
europepmc   +1 more source

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements. [PDF]

open access: yesJ Clin Invest
DiNapoli SR   +29 more
europepmc   +1 more source

Discovery and optimization of a synthetic small protein domain targeting antibodies. [PDF]

open access: yesFront Bioeng Biotechnol
Dias AMGC   +5 more
europepmc   +1 more source

A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART® Molecule for Treatment of Solid Tumors. [PDF]

open access: yesAntibodies (Basel)
Huang RR   +17 more
europepmc   +1 more source

Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis. [PDF]

open access: yesAppl Microbiol Biotechnol
Park EM   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy